USF Health joins national study on COVID-19 vaccine in young adults

Despite an ongoing COVID-19 surge hospitalizing more younger people, the 18-29 age group targeted by the Prevent COVID U trial has the lowest adult vaccination rates.

Getting your Trinity Audio player ready...

The USF Health Morsani College of Medicine in Tampa has begun enrolling university students and other young adults, including those not planning to be vaccinated, for an expanded nationwide study evaluating coronavirus infection and transmission in people ages 18 through 29. Individuals must not be vaccinated or have a positive SARS-CoV-2 test result before they start the study.

USF Health is one of more than 50 sites across the U.S. participating in the “Prevent COVID U” randomized controlled clinical trial. For this two-arm study using the Moderna COVID-19 mRNA vaccine, 6,000 individuals will be randomly selected to receive the vaccine right away at enrollment. Another 6,000 will be randomized to follow local guidance and their preference for vaccination timing or be vaccinated through the study after four months.

Read the complete story.
 

Author

With [X] years in digital journalism, [he/she/they] are committed to delivering high-quality, engaging stories. [Name] is passionate about innovation in media and fostering a collaborative editorial environment.

Our Partners

Solutions journalism takes time, trust, and your support.

Close
Psst. We could use your help today!

Don't miss out!

Everything Tampa Bay, in your inbox every week.

Close the CTA

Already a subscriber? Enter your email to hide this popup in the future.